Car makers face rising pressure to fix key management before risks build

Tern plc

As vehicles become more connected, software-led and dependent on secure data exchange, the way cryptographic keys are created, stored, rotated and retired has become central to operational resilience.

Every connected vehicle relies on trusted digital identities. These identities allow systems, devices and software to communicate securely. If the keys behind that trust are poorly managed, the risk is not limited to one system or one supplier. It can spread across production lines, supply chains, vehicle fleets and customer services.

Weak key management raises the risk of cyber incidents, compliance failures, delayed launches and higher remediation costs. Strong key management gives manufacturers a clearer path to secure scaling as connected vehicles and software-defined services become more important to future revenue.

Automotive cybersecurity requirements are tightening, while the number of connected components in vehicles continues to rise. Manual or fragmented processes are unlikely to be enough. Manufacturers need automated, scalable systems that can manage keys across the full lifecycle, from production through updates, servicing and eventual retirement.

Car makers depend on many partners, each with access to systems and devices that require secure credentials. A weak point in that chain can create wider exposure. Centralised key management improves control, auditability and consistency, which are increasingly important as regulators, customers and commercial partners demand higher standards.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Device Authority strengthens position in machine identity and Zero Trust Security

Device Authority’s inclusion in two 2026 Gartner Hype Cycle reports reinforces its positioning in machine identity, IoT authentication and Zero Trust security.

Talking Medicines highlights strategic value of patient journey intelligence

Patient journey intelligence can help healthcare organisations identify care barriers and design more responsive pathways around real patient experiences.

Evidence-based care pathways support more consistent healthcare delivery

Evidence-based care pathways can improve diagnosis, treatment consistency and the integration of new therapies into routine care.

Tern increases Talking Medicines funding and raises shareholder distribution commitment

Tern has invested in additional Talking Medicines convertible loan notes and increased its minimum shareholder distribution commitment to 70% on qualifying exits.

Evidence-based care pathways create clearer routes to adoption

Evidence-based care pathways can reduce delays, improve treatment consistency and support the adoption of new therapies.

Talking Medicines highlights the data opportunity emerging around GLP-1 care

Talking Medicines examines how the expanding GLP-1 market is increasing the importance of clear distinctions between approved therapies, compounded medicines and nutritional support.

Search